BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.25%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.01B
AUM Growth
+$1.01B
(+5.4%)
Cap. Flow
+$23.9M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
32.72%
Holding
140
New
6
Increased
28
Reduced
48
Closed
16
Top Buys
| 1 |
Teladoc Health
TDOC
|
$18.9M |
| 2 |
Humana
HUM
|
$13.5M |
| 3 |
KTWO
K2M Group Holdings, Inc
KTWO
|
$12.7M |
| 4 |
Esperion Therapeutics
ESPR
|
$11.9M |
| 5 |
FIT
Fitbit, Inc. Class A common stock
FIT
|
$11.7M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$20.4M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.6M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$10.6M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$9.94M |
| 5 |
Tenet Healthcare
THC
|
$9.34M |
Sector Composition
| 1 | Healthcare | 95.24% |
| 2 | Industrials | 0.39% |
| 3 | Financials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONC
51
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $6.83M | 0.68% | 40,650 -63,000 | -61% | -$10.6M |
|
|
GNMK
52
DELISTED
GenMark Diagnostics, Inc
GNMK
| $6.46M | 0.64% | 1,186,502 +412,825 | +53% | +$2.25M |
|
53
Cooper Companies
COO
$13.4B
| $5.1M | 0.51% | 22,300 | – | – |
|
54
Thermo Fisher Scientific
TMO
$186B
| $4.92M | 0.49% | 23,848 -1,960 | -8% | -$405K |
|
55
Neurocrine Biosciences
NBIX
$13.8B
| $4.45M | 0.44% | 53,650 -850 | -2% | -$70.5K |
|
56
Nektar Therapeutics
NKTR
$568M
| $3.77M | 0.37% | 35,500 -39,200 | -52% | -$4.17M |
|
|
CERN
57
DELISTED
Cerner Corp
CERN
| $3.71M | 0.37% | 64,000 +20,000 | +45% | +$1.16M |
|
58
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.6M | 0.36% | 44,350 -700 | -2% | -$56.7K |
|
59
Teleflex
TFX
$5.59B
| $3.57M | 0.35% | 14,000 | – | – |
|
60
Molina Healthcare
MOH
$9.8B
| $3.53M | 0.35% | 43,500 | – | – |
|
|
ESRX
61
DELISTED
Express Scripts Holding Company
ESRX
| $3.42M | 0.34% | 49,500 | – | – |
|
62
Agios Pharmaceuticals
AGIO
$2.19B
| $3.3M | 0.33% | 40,300 -600 | -1% | -$49.1K |
|
63
Alkermes
ALKS
$4.78B
| $2.95M | 0.29% | 50,900 -800 | -2% | -$46.4K |
|
64
Henry Schein
HSIC
$8.44B
| $2.89M | 0.29% | 43,000 | – | – |
|
65
Ligand Pharmaceuticals
LGND
$3.15B
| $2.75M | 0.27% | 16,650 -8,750 | -34% | -$1.45M |
|
66
Perrigo
PRGO
$3.27B
| $2.75M | 0.27% | 33,000 | – | – |
|
67
Dentsply Sirona
XRAY
$2.85B
| $2.74M | 0.27% | 54,500 | – | – |
|
68
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.59M | 0.26% | 21,750 -350 | -2% | -$41.7K |
|
69
Johnson & Johnson
JNJ
$427B
| $2.56M | 0.25% | 20,000 -6,000 | -23% | -$769K |
|
|
SGEN
70
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.56M | 0.25% | 48,850 -4,650 | -9% | -$243K |
|
71
Bristol-Myers Squibb
BMY
$96B
| $2.53M | 0.25% | +40,000 | New | +$2.53M |
|
72
Globus Medical
GMED
$8.27B
| $2.43M | 0.24% | 48,850 | – | – |
|
|
BLUE
73
DELISTED
bluebird bio
BLUE
| $2.27M | 0.23% | 13,300 -5,800 | -30% | -$990K |
|
|
TRHC
74
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.25M | 0.22% | 58,000 | – | – |
|
|
AGN
75
DELISTED
Allergan plc
AGN
| $2.19M | 0.22% | 13,000 -3,500 | -21% | -$589K |
|